Physicians who were alerted about scarce supplies ordered 29 percent fewer blood clotting tests, according to a study published July 18 in Jama Internal Medicine. The reduced level of tests ordered lasted for months after the shortage alerts were initially introduced.
Previous studies have suggested that as much as 90 percent of some tests with the blue top tubes are not clinically indicated, the study said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
